4//SEC Filing
Quane Alessandrea C. 4
Accession 0001562180-24-006658
CIK 0001568651other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 8:36 PM ET
Size
27.1 KB
Accession
0001562180-24-006658
Insider Transaction Report
Form 4
Quane Alessandrea C.
EVP, Chief Insurance Officer
Transactions
- Sale
Class A Common Stock
2024-09-04$17.85/sh−31,616$564,346→ 378,150 total - Exercise/Conversion
Class A Common Stock
2024-09-01+34,380→ 292,532 total - Exercise/Conversion
Class A Common Stock
2024-09-01+224,503→ 517,035 total - Exercise/Conversion
Class A Common Stock
2024-09-01+8,652→ 525,687 total - Exercise/Conversion
Class A Common Stock
2024-09-01+7,016→ 258,152 total - Sale
Class A Common Stock
2024-09-03$17.99/sh−77,181$1,388,486→ 448,506 total - Sale
Class A Common Stock
2024-09-04$17.46/sh−38,740$676,400→ 409,766 total - Exercise/Conversion
Restricted Stock Units
2024-09-01−7,016→ 28,063 total→ Class A Common Stock (7,016 underlying) - Exercise/Conversion
Restricted Stock Units
2024-09-01−34,380→ 343,796 total→ Class A Common Stock (34,380 underlying) - Exercise/Conversion
Restricted Stock Units
2024-09-01−8,652→ 86,525 total→ Class A Common Stock (8,652 underlying)
Holdings
- 76,857(indirect: Alessandrea C Quane 2024 GRAT)
Class A Common Stock
Footnotes (9)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The Issuer previously granted the Reporting Person an award of 224,503 restricted stock units that vested on September 1, 2024, following the Talent & Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved.
- [F3]The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F7]The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
- [F8]The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
- [F9]The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.
Documents
Issuer
Oscar Health, Inc.
CIK 0001568651
Entity typeother
Related Parties
1- filerCIK 0001667819
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 8:36 PM ET
- Size
- 27.1 KB